Teleflex, trading under TFX, may finalize a deal to purchase Biotronik’s vascular intervention segment by the end of this month. Reports from December 4, as published by Bloomberg, revealed inside information indicating that Teleflex is contemplating an offer ranging from […]
Teleflex Engages in Potential Acquisition of Biotronik’s Stent Division Read More »
Abbott (NYSE: ABT) today announced the landmark completion of the initial human cases of leadless left bundle branch area pacing (LBBAP). The pioneering procedures, conducted using Abbott’s investigational Aveir conduction system pacing (CSP) leadless pacemaker, are part of an exploratory
Abbott Achieves Milestone with First Leadless Left Bundle Branch Area Pacing Procedures Read More »
FDA Raises Alert Following Boston Scientific’s Caution on Early Pacemaker Replacement In a recent announcement, Boston Scientific (NYSE: BSX) revealed the potential necessity for earlier-than-anticipated replacements of specific pacemaker models. This alert prompted the FDA to issue a notice to
Potential Early Replacement Required for Some Boston Scientific Pacemakers Read More »
Withings Health Solutions proudly announced FDA clearance for their innovative cellular blood pressure monitor, BPM Pro 2. This breakthrough device aims to transform clinical workflows by offering seamless measurement of blood pressure and pulse rate for adults with varying arm
FDA Approves Withings’ Revolutionary Blood Pressure Monitor Read More »
Adagio Medical (Nasdaq: ADGM) has revealed its new leadership decision with the appointment of Todd Usen as CEO and board director. The decision comes after the recent exit of Olav Bergheim, who was the founder, CEO, and board chair. Bergheim’s
Adagio Medical Appoints Todd Usen as CEO, Bringing Extensive Medtech Experience Read More »
HeartBeam (Nasdaq:BEAT) has announced the approval of its comprehensive arrhythmia assessment system by the FDA, under 510(k) clearance. The innovative device, developed by the Santa Clara, California-based company, is the first of its kind to earn such approval. This advanced
HeartBeam Secures FDA Approval for Home-Based ECG Technology Read More »
FastWave Medical revealed today it has successfully completed a funding round, surpassing expectations to secure $19 million in proceeds. Based in Minneapolis, FastWave focuses on the development of intravascular lithotripsy (IVL) technology. This latest financing elevates their total funding to
FastWave Secures $19 Million to Advance Its IVL Solutions Read More »
Boston Scientific (NYSE: BSX) has named Kathleen Van Vlierberghe as Vice President for Peripheral Interventions in the Europe, Middle East, and Africa (EMEA) region. Her new role commenced on December 1, 2024. Van Vlierberghe joins this position with over 25
Boston Scientific Appoints New Leader for Peripheral Interventions in EMEA Read More »
Precision Neuroscience, a developer of brain-computer interfaces, has successfully completed a Series C funding round, acquiring $102 million in investment. Spearheaded by General Equity Holdings, this round elevates the total fundraising figure to $155 million for the company. Joining this
Precision Neuroscience Secures $102M for BCI Development Read More »
HistoSonics revealed today that they have successfully treated their first set of patients with pancreatic tumors, utilizing their Edison histotripsy system. This milestone is part of the GANNON trial and signifies the Minneapolis-based company’s venture into a new area of
HistoSonics Broadens its Reach to Address Pancreatic Cancer with New Therapy Read More »